Rochester Center for Behavioral Medicine
Open enrollment with a later-stage pipeline tilt
According to ClinicalTrials.gov-derived indexes, Rochester Center for Behavioral Medicine sits in the upper quartile of US sponsors by registered trial count (#2,913 of 15,742 sponsors by registered trial count).
Rochester Center for Behavioral Medicine: 4 sponsored US clinical trials, 1 recruiting.
Rochester Center for Behavioral Medicine sponsors 4 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 3 completed. 4 of these trials are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Adult Attention Deficit Hyperactivity Disorder, with 1 trials.
Upper-quartile sponsor footprint
Rochester Center for Behavioral Medicine sits in the upper quartile of the sponsor corpus (#2,913 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
4 total, page 1 of 1
A Trial of Dyanavel XR in Treating Co-occurring Fatigue Symptoms in Adults With Attention Deficit Hyperactivity Disorder (ADHD).
NCT06248229
A Trial of Solriamfetol in the Treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
NCT04622293
Efficacy and Safety Eval of Guanfacine Hydrochloride in Combination With Psychostimulants in Adults (18-65).
NCT02141113
Efficacy and Safety of Lisdexamfetamine Dimesylate in Adults With Chronic Fatigue Syndrome
NCT01071044
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 4 | 4 |
Where Rochester Center for Behavioral Medicine enrollment is open (later-stage tilt)
1 recruiting of 4 indexed (25% open); 3 completed (75%).
Phase mix: 4 late (III/IV) vs 0 early (I/II) (later-stage heavy).
Top condition: Adult Attention Deficit Hyperactivity Disorder (1 trial), 3 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Rochester Center for Behavioral Medicine: open-pipeline peers nationwide
Peers matched on 4 registered trials and 25% open enrollment, not the therapeutic-area sidebar.
Rochester Center for Behavioral Medicine sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 4 trials (± recruiting share)
- 4D pharma · 4 trials · 0% recruiting
- 60 Degrees Pharmaceuticals · 4 trials · 50% recruiting
- A2 Biotherapeutics · 4 trials · 75% recruiting
- Abdul Latif Jameel Poverty Action Lab · 4 trials · 25% recruiting
Sponsors near 25% open enrollment (± trial volume)
- AB Science · 25% recruiting · 8 trials
- Abbott Point of Care · 25% recruiting · 8 trials
- Accutar Biotechnology · 25% recruiting · 4 trials
- Adrienne G. Waks · 25% recruiting · 4 trials
Related
What to do with this Rochester Center for Behavioral Medicine page
4 registered trials is a research-attention snapshot, not an endorsement of Rochester Center for Behavioral Medicine or any single study.
- 1 of Rochester Center for Behavioral Medicine's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Adult Attention Deficit Hyperactivity Disorder is the condition Rochester Center for Behavioral Medicine studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Adult Attention Deficit Hyperactivity Disorder trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Rochester Center for Behavioral Medicine pipeline card: 4 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.